HIGHLIGHTS
- who: Report and colleagues from the Internal Medicine, American University of Antigua, New York City, USA General Surgery, Mayo Clinic, Rochester have published the article: Review began 06/10/2022 Review ended 07/22/2022 Published 07/24/2022 © Copyright, in the Journal: (JOURNAL) of July/24,/2022
- what: This study showed a female predominance among cases, with 55% of patients being female, making this a significant risk factor for VITT .
- how: The patient's serum was tested for heparin-platelet factor 4 (heparin-PF4) antibodies.
SUMMARY
Few serious . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.